COLUMBUS, Ga., Jan. 30 /PRNewswire-FirstCall/ -- Aflac Incorporated
(NYSE: AFL) today reported its fourth quarter results.
Total revenues benefited from the strengthening of the yen to the
dollar in the fourth quarter, rising 9.0% to $4.0 billion, compared with
$3.7 billion in the fourth quarter of 2006. Net earnings were $382 million,
or $.78 per diluted share, compared with $332 million, or $.67 per share, a
year ago. Net earnings included realized investment losses of $1 million,
or nil per diluted share, compared with a gain of $3 million, or $.01 per
diluted share in the fourth quarter of 2006. The change in fair value of
the interest rate component of the cross-currency swaps related to the
company's senior notes, as required by SFAS 133, increased net earnings by
$1 million, or nil per diluted share, in the fourth quarter of 2007. The
impact from SFAS 133 in the fourth quarter of 2006 was immaterial to net
earnings and net earnings per diluted share.
We believe that an analysis of operating earnings, a non-GAAP financial
measure, is vitally important to an understanding of Aflac's underlying
profitability drivers. We define operating earnings as the profits we
derive from our operations before realized investment gains and losses, the
impact from SFAS 133, and nonrecurring items. Management uses operating
earnings to evaluate the financial performance of Aflac's insurance
operations because realized gains and losses, the impact from SFAS 133, and
nonrecurring items tend to be driven by general economic conditions and
events, and therefore may obscure the underlying fundamentals and trends in
Aflac's insurance operations.
Furthermore, because a significant portion of our business is in Japan,
where our functional currency is the Japanese yen, we believe it is equally
important to understand the impact on operating earnings from translating
yen into dollars. We translate Aflac Japan's yen-denominated income
statement from yen into dollars using an average exchange rate for the
reporting period, and we translate the balance sheet using the exchange
rate at the end of the period. However, except for a limited number of
transactions, we do not actually convert yen into dollars. As a result, we
view foreign currency translation as a financial reporting issue for Aflac
and not as an economic event to our company or shareholders. Because
changes in exchange rates distort the growth rates of our operations, we
also encourage readers of our financial statements to evaluate our
financial performance excluding the impact of foreign currency translation.
The chart at the end of this release presents a comparison of selected
income statement items with and without foreign currency changes to
illustrate the effect of currency translation.
Operating earnings in the fourth quarter of 2007 were $382 million,
compared with $329 million in the fourth quarter of 2006. Operating
earnings per diluted share rose 18.2% to $.78, which was consistent with
the expectations we communicated in our third quarter earnings release,
compared with $.66 per share a year ago. Operating earnings in the fourth
quarter benefited from a change in accounting for internal replacements
(SOP 05-1), which increased operating earnings by $6 million, or $.01 per
diluted share, in the quarter. Operating earnings were also impacted by an
increase in benefit reserves for closed blocks of business in Japan and the
United States. The increase in reserves in the quarter lowered operating
earnings by $17 million, or $.03 per diluted share. The stronger yen/dollar
exchange rate increased operating earnings per diluted share by $.01 for
the fourth quarter.
For the full year of 2007, our results were suppressed by the weaker
yen/dollar exchange rate, compared with 2006. Total revenues were $15.4
billion, an increase of 5.3% over 2006. Net earnings were $1.6 billion, or
$3.31 per diluted share, compared with $1.5 billion, or $2.95 per share, in
2006. Full-year net earnings were impacted by lower realized investment
gains in 2007, compared with 2006. Realized investment gains were $19
million in 2007, or $.04 per diluted share, compared with $51 million, or
$.10 per share, in 2006. The impact of SFAS 133 was immaterial for both
2007 and 2006.
Operating earnings for the year were $1.6 billion, or $3.27 per diluted
share, compared with $1.4 billion, or $2.85 per share, in 2006. Excluding
the negative impact of $.02 per share from the weaker yen, operating
earnings per diluted share rose 15.4% for the year. That result was in line
with our 2007 objective of a 15% to 16% increase in operating earnings per
diluted share before the impact of currency translation.
During the fourth quarter, we acquired 2.0 million shares of our stock,
bringing the total number of shares purchased in 2007 to 11.1 million.
AFLAC JAPAN
Aflac Japan premium income in yen rose 4.0% in the fourth quarter. Net
investment income increased 4.6%. Investment income growth in yen terms was
lowered somewhat by the stronger yen/dollar exchange rate because
approximately 38% of Aflac Japan's fourth quarter investment income was
dollar-denominated. Total revenues were up 4.2%. Despite the previously
mentioned adjustment to Aflac Japan benefit reserves, the benefit ratio
improved over a year ago. As a result, the pretax operating profit margin
expanded from 14.7% to 15.0%. Pretax operating earnings in yen increased
5.8%. For the year, premium income in yen increased 4.3%, and net
investment income rose 8.0%. Total revenues were up 4.9%, and pretax
operating earnings grew 11.8%.
The average yen/dollar exchange rate in the fourth quarter of 2007 was
113.24, or 4.1% stronger than the average rate of 117.88 in the fourth
quarter of 2006. Although the yen strengthened in relation to the dollar in
the fourth quarter of 2007, the average yen/dollar exchange rate was weaker
for the full year, compared with 2006. For the year, the average exchange
rate was 117.93 in 2007, or 1.4% weaker than the rate of 116.31 a year ago.
Benefiting from the stronger average yen in the fourth quarter, premium
income in dollars increased 8.3% to $2.4 billion. Net investment income
rose 8.9% to $466 million. Total revenues advanced 8.5% to $2.9 billion.
Pretax operating earnings were $428 million, or 10.2% higher than a year
ago. For the year, Aflac Japan's results in dollar terms were suppressed by
the weaker yen/dollar exchange rate in 2007. Premium income was $9.0
billion, up 3.1% from a year ago. Net investment income rose 6.7% to $1.8
billion. Total revenues were up 3.7% to $10.9 billion. Pretax operating
earnings were $1.8 billion, or 10.2% higher than a year ago.
Aflac Japan again posted sales gains that were in line with our
expectations. Total new annualized premium sales rose 2.7% to 30.3 billion
yen, or $268 million, in the fourth quarter. For the year, total new
annualized premium sales were down 2.4% to 114.6 billion yen, or $974
million. Although overall sales growth was again constrained by weakness in
Rider MAX sales, stand-alone medical sales were strong, rising 16.8% for
the quarter. Sales of medical insurance benefited from our new nonstandard
medical product, Gentle EVER. At the same time, we were pleased with the
sale of our cancer life insurance. Cancer life sales were down only
slightly in the quarter, compared with a year ago. Our fourth quarter
cancer life sales followed a very strong third quarter that reflected our
agents' focus on selling the product in advance of a premium rate increase.
We believe the consumer acceptance of our newly introduced Cancer Forte
product helped to mitigate some of the sharp falloff in sales that usually
follows a premium rate increase.
AFLAC U.S.
Aflac U.S. premium income increased 10.9% to $1.0 billion. Net
investment income was up 6.2% to $127 million. Total revenues rose 10.4% to
$1.1 billion. Pretax operating earnings climbed 34.2% to $170 million,
which primarily reflected easy comparisons to the fourth quarter of 2006
when pretax operating earnings declined 1.8%. For the year, premium income
rose 10.8% to $3.9 billion. Net investment income increased 7.5% to $500
million. Total revenues were up 10.4% to $4.4 billion. Pretax operating
earnings rose 18.3% to $692 million.
As we expected, Aflac U.S. sales growth slowed somewhat in the fourth
quarter, compared with the first nine months of the year. Sales growth in
the fourth quarter of 2007 reflected difficult comparisons to the fourth
quarter of 2006 when sales benefited from the re-enrollment of a large
payroll account and rose 21.2%. Despite the tough comparison, total new
annualized premium sales were up 5.9% to $473 million in the fourth
quarter. For the year, total new annualized premium sales increased 9.5% to
a record $1.6 billion. Our sales results for the year were consistent with
our 2007 sales objective of a 6% to 10% increase. Sales in the fourth
quarter benefited from solid contributions in the hospital indemnity and
cancer insurance lines. Fourth quarter sales also reflected an
administrative change in the timing of sales associates' production credit
for delay-bill policy conversions. This change accelerated approximately $8
million of conversion premiums from the first quarter of 2008 to the fourth
quarter of 2007. Excluding the impact of the change in conversion
processing, total new annualized premium sales were up 4.0% for the fourth
quarter and 8.9% for the year.
We continue to believe that expansion of our sales force is an
important key to sales growth. As we have repeatedly discussed, we have
been intensely focused on increasing the number of producing sales
associates. On an average weekly basis, the number of producing associates
was up 5.4% in the fourth quarter and 6.0% for the year.
OUTLOOK
Commenting on the company's fourth quarter and full-year results,
Chairman and Chief Executive Officer Daniel P. Amos stated: "I am very
pleased with our results for 2007. Aflac Japan and Aflac U.S. each achieved
their sales objectives and produced strong financial results in 2007, which
contributed to a record year in terms of operating earnings. I am
especially proud that we achieved our primary financial objective of a 15%
to 16% increase in operating earnings per diluted share, before the impact
of currency translation. 2007 was the 18th year in which we have increased
operating earnings per diluted share by at least 15% before the impact of
the yen.
"From a financial perspective Aflac Japan had both a strong fourth
quarter and full year. Our top-line growth was in line with our
expectations, and as we expected, the benefit ratio continued to improve,
resulting in expanded profit margins and strong pretax earnings growth. At
the same time, Aflac Japan built sales momentum throughout the year, which
we expect to continue in 2008. We look forward to new distribution
opportunities through the bank channel and Japan Post, and we believe our
product portfolio is well-positioned in the Japanese market. Our sales
objective for 2008 is an increase of 3% to 7%.
"Aflac U.S. also performed very well throughout the year. Our U.S.
operation generated strong financial results, highlighted by improved
operating trends and strong earnings growth. We were again pleased with the
sales momentum of Aflac U.S. We believe our sales growth reflects a quality
product line and enhanced training to a steadily growing sales force. As we
noted, sales in the fourth quarter benefited from the change in our
conversion processing practices, and will take away from first-quarter 2008
sales. As a result, we expect Aflac U.S. sales will be weak in the first
quarter. However, we believe a sales increase of 8% to 12% is an achievable
objective for 2008. We remain enthusiastic about the sales opportunities of
the vast and underpenetrated U.S. market.
"I believe our earnings outlook for 2008 remains very promising. Our
objective for 2008 is to increase operating earnings per diluted share 13%
to 15%, or $3.70 to $3.76, excluding the impact of the yen. Our confidence
in achieving that objective is based on the predictable earnings
characteristics of Aflac's large block of in-force business. Our earnings
target also reflects the opportunities we see in Japan and the United
States, as well as the product, distribution and branding strengths we
bring to these two large markets. We will continue to build on our
strengths and position Aflac for another record year."
For more than 50 years, Aflac products have given policyholders the
opportunity to direct cash where it is needed most when a life-interrupting
medical event causes financial challenges. Aflac is the number one provider
of guaranteed-renewable insurance in the United States and the number one
insurance company in terms of individual insurance policies in force in
Japan. Our insurance products provide protection to more than 40 million
people worldwide. Aflac has been included in Fortune magazine's listing of
America's Most Admired Companies for seven consecutive years and in Fortune
magazine's list of the 100 Best Companies to Work For in America for ten
consecutive years. Aflac has also been recognized three times by both
Fortune magazine's listing of the Top 50 Employers for Minorities and
Working Mother magazine's listing of the 100 Best Companies for Working
Mothers. Aflac Incorporated is a Fortune 500 company listed on the New York
Stock Exchange under the symbol AFL. To find out more about Aflac, visit
aflac.com.
A copy of Aflac's Financial Analyst Briefing (FAB) supplement for the
fourth quarter of 2007 can be found on the "Investors" page at aflac.com.
Aflac Incorporated will webcast its fourth quarter presentation via the
"Investors" page of aflac.com at 6:40 p.m. (EST) on Thursday, January 31.
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT
(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)
THREE MONTHS ENDED DECEMBER 31, 2007 2006 % Change
Total revenues $4,018 $3,687 9.0%
Benefits and claims 2,431 2,300 5.7
Total acquisition and
operating expenses 1,002 880 13.8
Earnings before income taxes 585 507 15.4
Income taxes 203 175
Net earnings $382 $332 15.1%
Net earnings per share
- basic $.79 $.67 17.9%
Net earnings per share
- diluted .78 .67 16.4
Shares used to compute
earnings per share (000):
Basic 486,017 492,614 (1.3)%
Diluted 492,240 498,564 (1.3)
Dividends paid per share $.205 $.16 28.1%
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT
(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)
TWELVE MONTHS ENDED DECEMBER 31, 2007 2006 % Change
Total revenues $15,393 $14,616 5.3%
Benefits and claims 9,285 9,016 3.0
Total acquisition and
operating expenses 3,609 3,336 8.2
Earnings before income taxes 2,499 2,264 10.4
Income taxes 865 781
Net earnings $1,634 $1,483 10.2%
Net earnings per share
- basic $3.35 $2.99 12.0%
Net earnings per share
- diluted 3.31 2.95 12.2
Shares used to compute
earnings per share (000):
Basic 487,869 495,614 (1.6)%
Diluted 493,971 501,827 (1.6)
Dividends paid per share $.80 $.55 45.5%
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET
(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AMOUNTS)
DECEMBER 31, 2007 2006 % Change
Assets:
Total investments and cash $57,056 $51,972 9.8%
Deferred policy acquisition
costs 6,654 6,025 10.4
Other assets 2,095 1,808 15.9
Total assets $65,805 $59,805 10.0%
Liabilities and shareholders'
equity:
Policy liabilities $50,676 $45,440 11.5%
Notes payable 1,465 1,426 2.7
Other liabilities 4,869 4,598 5.9
Shareholders' equity 8,795 8,341 5.4
Total liabilities and
shareholders' equity $65,805 $59,805 10.0%
Shares outstanding at
end of year (000) 486,530 492,550 (1.2)%
RECONCILIATION OF OPERATING EARNINGS TO NET EARNINGS
(UNAUDITED - IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)
THREE MONTHS ENDED DECEMBER 31, 2007 2006 % Change
Operating earnings $382 $329 15.9%
Reconciling items, net of tax:
Realized investment gains
(losses) (1) 3
Impact from SFAS 133 1 -
Net earnings $382 $332 15.1%
Operating earnings per diluted
share $.78 $.66 18.2%
Reconciling items, net of tax:
Realized investment gains
(losses) - .01
Impact from SFAS 133 - -
Net earnings per diluted share $.78 $.67 16.4%
RECONCILIATION OF OPERATING EARNINGS TO NET EARNINGS
(UNAUDITED - IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)
TWELVE MONTHS ENDED DECEMBER 31, 2007 2006 % Change
Operating earnings $1,613 $1,432 12.7%
Reconciling items, net of tax:
Realized investment gains
(losses) 19 51
Impact from SFAS 133 2 -
Net earnings $1,634 $1,483 10.2%
Operating earnings per diluted
share $3.27 $2.85 14.7%
Reconciling items, net of tax:
Realized investment gains
(losses) .04 .10
Impact from SFAS 133 - -
Net earnings per diluted share $3.31 $2.95 12.2%
FOREIGN CURRENCY TRANSLATION EFFECT ON OPERATING RESULTS(1)
(SELECTED PERCENTAGE CHANGES, UNAUDITED)
THREE MONTHS ENDED DECEMBER 31, 2007 Including Excluding
Currency Currency
Changes Changes(2)
Premium income 9.0% 6.0%
Net investment income 8.4 6.4
Total benefits and expenses 7.9 5.0
Operating earnings 15.9 13.9
Operating earnings per diluted share 18.2 16.7
(1) The numbers in this table are presented on an operating basis, as
previously described.
(2) Amounts excluding currency changes were determined using the same
yen/dollar exchange rate for the current period as the comparable
period in the prior year.
FOREIGN CURRENCY TRANSLATION EFFECT ON OPERATING RESULTS(1)
(SELECTED PERCENTAGE CHANGES, UNAUDITED)
TWELVE MONTHS ENDED DECEMBER 31, 2007 Including Excluding
Currency Currency
Changes Changes(2)
Premium income 5.4% 6.2%
Net investment income 7.5 8.1
Total benefits and expenses 4.4 5.2
Operating earnings 12.7 13.4
Operating earnings per diluted share 14.7 15.4
(1) The numbers in this table are presented on an operating basis, as
previously described.
(2) Amounts excluding currency changes were determined using the same
yen/dollar exchange rate for the current period as the comparable
period in the prior year.
The Private Securities Litigation Reform Act of 1995 provides a "safe
harbor" to encourage companies to provide prospective information, so long
as those informational statements are identified as forward-looking and are
accompanied by meaningful cautionary statements identifying important
factors that could cause actual results to differ materially from those
included in the forward-looking statements. We desire to take advantage of
these provisions. This document contains cautionary statements identifying
important factors that could cause actual results to differ materially from
those projected herein, and in any other statements made by company
officials in communications with the financial community and contained in
documents filed with the Securities and Exchange Commission (SEC).
Forward-looking statements are not based on historical information and
relate to future operations, strategies, financial results or other
developments. Furthermore, forward-looking information is subject to
numerous assumptions, risks, and uncertainties. In particular, statements
containing words such as "expect," "anticipate," "believe," "goal,"
"objective," "may," "should," "estimate," "intends," "projects," "will,"
"assumes," "potential," "target," or similar words as well as specific
projections of future results, generally qualify as forward-looking. Aflac
undertakes no obligation to update such forward-looking statements.
We caution readers that the following factors, in addition to other
factors mentioned from time to time could cause actual results to differ
materially from those contemplated by the forward-looking statements:
legislative and regulatory developments; assessments for insurance company
insolvencies; competitive conditions in the United States and Japan; new
product development and customer response to new products and new marketing
initiatives; ability to attract and retain qualified sales associates and
employees; ability to repatriate profits from Japan; changes in U.S. and/or
Japanese tax laws or accounting requirements; credit and other risks
associated with Aflac's investment activities; significant changes in
investment yield rates; fluctuations in foreign currency exchange rates;
deviations in actual experience from pricing and reserving assumptions
including, but not limited to, morbidity, mortality, persistency, expenses,
and investment yields; level and outcome of litigation; downgrades in the
company's credit rating; changes in rating agency policies or practices;
subsidiary's ability to pay dividends to parent company; ineffectiveness of
hedging strategies; catastrophic events; and general economic conditions in
the United States and Japan, including increased uncertainty in the U.S.
and international financial markets.
(Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO )
Analyst and investor contact - Kenneth S. Janke Jr., 800.235.2667, opt.
3, FAX: 706.324.6330, or kjanke@aflac.com
Media contact - Laura Kane, 706.596.3493, FAX: 706.320.2288, or
lkane@aflac.com
SOURCE Aflac Incorporated
 back to top
Related links:
http://www.aflac.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Analyst and investors, Kenneth S. Janke Jr.,
1-800-235-2667, opt. 3, FAX: +1-706-324-6330, kjanke@aflac.com,
or Media, Laura Kane, +1-706-596-3493, FAX: +1-706-320-2288,
lkane@aflac.com, both of Aflac Incorporated
|
